Cancer Diagnostics and Precision Medicine

Cancer Diagnostics and Precision Medicine is organized by Florida Society of Pathologists (FSP).

Release Date: December 9, 2024
Expiration Date: December 9, 2025

Description:
Recent advances in molecular diagnostics and drug development have revolutionized how cancer is being diagnosed, risk stratified and treated. A host of new targeted therapies and immunotherapies have emerged, and many require companion diagnostic testing to identify which patients are most likely to respond to these therapies. This activity will cover recent advances in cancer diagnostics, with a focus on integrating precision medicine approaches. Topics will cover the latest molecular and genomic biomarkers used in cancer diagnostics, including their clinical implications for targeted therapies. Learners will gain insights into selecting and interpreting biomarker tests that drive individualized treatment decisions and improve patient outcomes.

Learning Objectives:
At the conclusion of this activity, learners should be better able to:

• Define the role of precision medicine in enhancing the diagnostic accuracy and management of cancer.
• Identify key molecular and genomic biomarkers used in cancer diagnostics.
• Integrate precision medicine principles into routine pathology practice to guide targeted therapy decisions.